The global Liver Protection Tablets market is witnessing sustained expansion, driven by rising cases of liver disorders, the global surge in metabolic diseases, and heightened consumer interest in preventive wellness. Valued at USD 641 million in 2024, the market is projected to grow to USD 894 million by 2031, reflecting a CAGR of 5.0%. Growing awareness of liver health’s critical role...